Back to Search Start Over

Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency

Authors :
van Wessel, Daan B. E. Thompson, Richard J. Gonzales, Emmanuel and Jankowska, Irena Shneider, Benjamin L. Sokal, Etienne and Grammatikopoulos, Tassos Kadaristiana, Agustina Jacquemin, Emmanuel Spraul, Anne Lipinski, Patryk Czubkowski, Piotr and Rock, Nathalie Shagrani, Mohammad Broering, Dieter Algoufi, Talal Mazhar, Nejat Nicastro, Emanuele Kelly, Deirdre and Nebbia, Gabriella Arnell, Henrik Fischler, Bjorn Hulscher, Jan B. F. Serranti, Daniele Arikan, Cigdem Debray, Dominique and Lacaille, Florence Goncalves, Cristina Hierro, Loreto and Bartolo, Gema Munoz Mozer-Glassberg, Yael Azaz, Amer and Brecelj, Jernej Dezsofi, Antal Calvo, Pier Luigi and Krebs-Schmitt, Dorothee Hartleif, Steffen van der Woerd, Wendy L. Wang, Jian-She Li, Li-Ting Durmaz, Ozlem Kerkar, Nanda Jorgensen, Marianne Horby Fischer, Ryan and Jimenez-Rivera, Carolina Alam, Seema Cananzi, Mara and Laverdure, Noemie Ferreira, Cristina Targa Ordonez, Felipe and Wang, Heng Sency, Valerie Kim, Kyung Mo Chen, Huey-Ling and Carvalho, Elisa Fabre, Alexandre Bernabeu, Jesus Quintero and Alonso, Estella M. Sokol, Ronald J. Suchy, Frederick J. and Loomes, Kathleen M. McKiernan, Patrick J. Rosenthal, Philip and Turmelle, Yumirle Rao, Girish S. Horslen, Simon Kamath, Binita M. Rogalidou, Maria Karnsakul, Wikrom W. Hansen, Bettina Verkade, Henkjan J. Nat Course Prognosis PFIC Effect B
Publication Year :
2021

Abstract

BACKGROUND AND AIMS: Mutations in ATPase phospholipid transporting 8B1 (ATP8B1) can lead to familial intrahepatic cholestasis type 1 (FIC1) deficiency, or progressive familial intrahepatic cholestasis type 1. The rarity of FIC1 deficiency has largely prevented a detailed analysis of its natural history, effects of predicted protein truncating mutations (PPTMs), and possible associations of serum bile acid (sBA) concentrations and surgical biliary diversion (SBD) with long-term outcome. We aimed to provide insights by using the largest genetically defined cohort of patients with FIC1 deficiency to date. APPROACH AND RESULTS: This multicenter, combined retrospective and prospective study included 130 patients with compound heterozygous or homozygous predicted pathogenic ATP8B1 variants. Patients were categorized according to the number of PPTMs (i.e., splice site, frameshift due to deletion or insertion, nonsense, duplication), FIC1-A (n = 67; no PPTMs), FIC1-B (n = 29; one PPTM), or FIC1-C (n = 34; two PPTMs). Survival analysis showed an overall native liver survival (NLS) of 44% at age 18 years. NLS was comparable among FIC1-A, FIC1-B, and FIC1-C (% NLS at age 10 years: 67%, 41%, and 59%, respectively; P = 0.12), despite FIC1-C undergoing SBD less often (% SBD at age 10 years: 65%, 57%, and 45%, respectively; P = 0.03). sBAs at presentation were negatively associated with NLS (NLS at age 10 years, sBAs < 194 mu mol/L: 49% vs. sBAs >= 194 mu mol/L: 15%; P = 0.03). SBD decreased sBAs (230 [125-282] to 74 [11-177] mu mol/L; P = 0.005). SBD (HR 0.55, 95% CI 0.28-1.03, P = 0.06) and post-SBD sBA concentrations < 65 mu mol/L (P = 0.05) tended to be associated with improved NLS. CONCLUSIONS: Less than half of patients with FIC1 deficiency reach adulthood with native liver. The number of PPTMs did not associate with the natural history or prognosis of FIC1 deficiency. sBA concentrations at initial presentation and after SBD provide limited prognostic information on long-term NLS.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......2127..fe3bf1f92917057d9a7452855906c5c5